Celldex Therapeutics Inc. (CLDX)
Market Closed
16 Oct, 08:00 PM
$
27. 53
-1.4
-4.8393%
$
1.99B Market Cap
- P/E Ratio
- Div Yield
997,946 Volume
-3.01 Eps
$ 28.93
Previous Close 
Want to track CLDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Celldex Therapeutics Inc. (CLDX) Statistics
Valuation metrics
Market Cap 1.99B
Enterprise value 1.95B
Trailing P/E (ttm) -6.86
Forward P/E -
PEG ratio 0.2
Price/Sales (ttm) 17,757.45
Price/Book (mrq) 3.26
Enterprise Value/Revenue 17,377.54
Enterprise Value/EBITDA -6.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.02M
Average volume (90 days) 1.31M
Price summary
52-Week low 22.1
52-Week high 45.14
Beta -
50-Day moving average 33.77
200-Day moving average 33.62
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 11 Feb 2019
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2,683.86%
Operating margin -2,909.48%
Operational effectiveness
Return on assets -0.38%
Return on equity -0.52%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 11.82%
Book value per share (mrq) 9.18
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
